Elon Musk is reportedly considering an unconventional yet symbolic timeline for a potential SpaceX initial public offering, aiming to align the milestone with a rare planetary alignment and his own birthday in June 2026. According to a Financial Times report citing five people familiar with the discussions, the idea reflects Musk’s long-standing fascination with space, astronomy, and theatrics around major moments.
The report notes that SpaceX Chief Financial Officer Bret Johnsen has been actively engaging with existing private investors to gauge interest and sentiment around a possible IPO timeline. Since mid-December, Johnsen has reportedly held a series of meetings and Zoom calls with shareholders to explore the feasibility of taking SpaceX public around mid-2026. These conversations are said to be exploratory rather than definitive, but they signal a renewed internal discussion about the company’s future in public markets.
SpaceX, formally known as Space Exploration Technologies Corp., is one of the world’s most valuable private companies and a dominant player in the commercial space industry. The company operates the Falcon 9 and Falcon Heavy launch vehicles, supplies NASA with crewed missions via Crew Dragon, and is rapidly expanding its Starlink satellite internet constellation. An IPO would mark a major shift for the company, which Musk has historically been cautious about taking public due to concerns over short-term market pressures.
Musk, who will turn 55 in June 2026, is said to be intrigued by the idea of synchronizing the SpaceX IPO with both astronomical events and a personal milestone. While this approach may seem unusual by traditional financial standards, it aligns with Musk’s track record of blending symbolism, ambition, and storytelling into his business decisions.
At this stage, no formal IPO filing has been made, and SpaceX has not publicly confirmed any plans to go public. Market conditions, investor appetite, and SpaceX’s progress on key projects such as Starship are all expected to play a critical role in determining whether a 2026 SpaceX IPO ultimately moves forward.


Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth 



